Analgesics in Sri Lanka is expected to demonstrate resilience in 2026, achieving LKR7,078 million in retail value sales and a 3% year-on-year increase, despite a tightly regulated environment that has suppressed price-based rivalry and shifted the focus to supply reliability and distribution efficiency. The introduction of government price controls on 350 essential medicines, combined with heightened economic pressure, has sharpened consumer price sensitivity and spurred demand for smaller, more affordable pack sizes, especially in topical formats. For brands seeking to strengthen their position, prioritising reliable pharmacy distribution, expanding digital presence with affordable value packs and adapting to evolving consumer preferences for convenience and cost-efficiency are expected to remain essential to sustaining growth and capturing incremental demand in a market where regulatory and economic pressures are expected to persist.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Sri Lanka with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Sri Lanka, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Sri Lanka report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Sri Lanka?
- Which are the leading brands in Analgesics in Sri Lanka?
- How are products distributed in Analgesics in Sri Lanka?
- How has the regulatory and operating environment for Analgesics changed in Sri Lanka?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Price controls shift rivalry towards supply reliability
Iodex leverages retail e-commerce and value packs
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
OTC leaders to strengthen pharmacy networks as regulation limits brand rivalry
Affordable value packs and digital access to reshape pain relief choices
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Panadol maintains lead as rivals intensify promotions
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies sustain distribution dominance in analgesics
Daraz and Kapruka attract price-conscious buyers with digital promotions
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!